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Chapter 1: Introduction and Background
1.1 Sarcomere
In vertebrates, striated muscles are the contractile tissues responsible for
movement. Their contractile activity is regulated by a complex and interconnected
network of muscle proteins (Clark et al., 2002). The basic contractile unit in skeletal
and cardiac muscles is called the sarcomere, and is one of the most highly ordered
macromolecular assemblies in cells. The highly ordered macromolecular complexes
that make up the sarcomere can be divided into four major compartments: the Z-disc,
actin-containing thin filaments, myosin II-containing thick filaments, and the M-line.
The regions with myosin II-containing thick filaments are referred to as A-bands.
Regions where actin-containing thin filaments do not overlap with myosin II-
containing thick filaments are referred to as I-bands (Sparrow et al., 2009).
1.1.1 Z-disc
Z-discs form the boundaries of sarcomeres, and appear as dense lines under an
electron microscope. The size of the Z-disc is fiber type-specific, and ranges from
30–50 nm in fast muscles and 100–140 nm in slow muscles (Knöll et al., 2011). Z-
discs are localized at the center of thin filaments. Numerous proteins are present at a
Z-disc site, indicating the diverse functions of the Z-disc. α-Actinin is a major
component of Z-discs and plays an important role in Z-disc structure and function.
Loss-of-function mutations in α-actinin cause severe muscle defects in Drosophila
and C. elegans (Fyrberg et al., 1998; Moulder et al., 2010). It has been well-
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documented that α-actinin monomers interact to form antiparallel dimers, which
function as scaffolds linking sarcomeric contractile units in a series by anchoring the
thin filaments of adjacent sarcomeres (Frank et al., 2006; Sanger et al., 2010). In
addition to α-actinin, abundant intermediate filament proteins are localized at the
periphery of Z-discs and form links between adjacent myofibrils (Clark et al., 2002).
This linkage is critical for the passive transmission of tension, which can help
maintain the stability of the sarcomeric structure (Luther et al., 2009). In addition, the
Z-disc has been shown to play important roles in anchoring various proteins that are
associated with signal transduction and sensing stretch (Epstein and Davis 2003; Pyle
and Solaro 2004).
1.1.2 Thin filaments
Actin-containing thin filaments consist of double helix-polymerized actin
monomers, which span the I-band and overlap myosin filaments at the A-band
(Sparrow et al., 2009). Actin-containing thin filaments are anchored to Z-discs
through the fibrous barbed ends of actin. Actin filaments are decorated with the
regulatory proteins troponin and tropomyosin. Tropomyosin associates with actin
filaments and blocks actin-myosin interaction in the absence of or at low
concentrations of cytosolic Ca2+. In the presence of cytosolic Ca2+, troponin binds to
Ca2+ and undergoes a conformational change that allows the interaction of myosin
and actin. The interaction of myosin and actin in an ATP-dependent manner generates
the force required for movement. Several actin isoforms have been identified in
higher vertebrates and can be classified into tissue-specific muscle isoforms including
cardiac, skeletal, vascular, and enteric isoforms and two ubiquitous non-muscle
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isoforms (Vandekerckhove and Weber, 1979; Kumar et al., 1997). The amino acid
sequences of different actin isoforms are highly conserved. Interestingly, the
similarity of amino acid sequences does not translate into equivalent function. It has
been shown that the substitution of the indirect flight muscle actin with human β-
cytoplasmic actin in Drosophila impedes its ability to fly (Brault et al., 1999a; Brault
et al., 1999b). Although smooth muscle actin can partially rescue the cardiac actin
defect in cardiac α-actin-deficient mice, these mice are extremely hypertrophied, and
their heart function is severely disturbed (Kumar et al., 1997).
1.1.3 Thick filaments
Thick filaments are composed of several hundred myosin molecules, including
muscle myosin II. Myosin II molecules are grouped together to form the highly
ordered bipolar thick filaments and are responsible for the generation of muscle
contraction. Myosin II molecules can be characterized as a combination of two parts:
the head and the rod. The head region contains the globular head domains of N-
terminal myosin heavy chains as well as two pairs of light chains named the essential
and regulatory light chains. It has been well documented that myosin heavy chains
can form a catalytic motor and induce force (Sellers and Goodson, 1995). The
essential and regulatory light chains, which play regulatory roles in contraction, bind
to the heavy chains in the "neck" region between the head and tail. During contraction,
force is generated by the attachment of the myosin head motors to actin molecules in
an ATP-dependent manner (Boateng et al., 2008). Generally, the interaction of
myosin-actin-ATP complexes can produce a power stroke, which provides the force
for muscle movement. This process is regulated by the tropomyosin-troponin
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complex (Ruegg et al., 2002). The rod region of myosin II is also known as light
meromyosin (LMM). LMM contains long coiled-coil domains, which are responsible
for myosin polymerization (Clark et al., 2002). All the regions of myosin II molecules
are crucial for the proper functioning of thick filaments.
1.1.4 M-line
The M-line is localized to the middle of the A-band. The M-line plays a
regulatory role in packaging thick filaments and stabilizing the sarcomeric structure
(Knappeis et al., 1968). In the process of sarcomere alignment, the M-line is aligned
earlier than myosin, indicating a vital role for the M-line in regulating myosin
filament alignment (Yang et al., 2000). The interaction of the M-line and other
sarcomeric proteins is critical for sarcomere organization in myofibrillogenesis. It has
been reported that the M-line plays critical roles in cardiac myofibrillogenesis by
affecting titin filament organization (Wang et al., 1998). Biomedical and
physiological studies indicate that the M-line plays vital roles in transversing force
during the activation of contraction. It has been proposed that the M-line structure
might promote the symmetric shortening of the whole sarcomere (Agarkova et al.,
2003). These findings reflect the multiple roles of the M-line in the sarcomere.
Multiple proteins are localized on the M-line, such as myomesin, C-titin,
obscurin, and Muscle-specific RING finger proteins (MuRFs), which have diverse
functions. Targeted deletion of M-line-localized titin results in a failure to
differentiate at an early stage of myofibrillogenesis, indicating a critical role for M-
line-localized titin in sarcomere assembly (Musa et al., 2006). Some of the M-line
proteins link the sarcomere to other cellular structures and stabilize the myofiber. It
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has been shown that the giant protein obscurin, which is predominantly localized to
the M-line, helps stabilize the network of cross-linked myosin filaments by
functioning as a linker to the sarcoplasmic reticulum (Kontrogianni-Konstantopoulos
et al., 2009). In addition, M-line localized-proteins are involved in protein quality
control in myofibers. For example, the M-line proteins MuRFs, which are muscle-
specific RING-finger E3 ubiquitin ligases, are shown to play vital roles in regulating
protein degradation in muscles (Lange et al., 2005).
1.1.5 Myomesin
Myomesins are the leading candidates thought to play the role of M-band
bridges for regulating the packaging of thick filaments and distributing tension over
the thick filament lattice in a uniform manner (Agarkova et al., 2003). Members of
the myomesin family (myomesin 1, 2, and 3) are immunoglobulin (Ig)-like and
fibronectin (Fn) type III domain-containing proteins. Myomesin-1 demonstrates a
ubiquitous expression pattern and is found in all kinds of vertebrate striated muscles
(Agarkova et al., 2000; Agarkova et al., 2004). In contrast to the ubiquitously
expressed myomesin-1, M-protein (myomesin-2) and myomesin-3 are expressed in a
muscle-type and fiber type-specific pattern. Myomesin-2 is primarily found in fast-
type muscle fibers, and myomesin 3 is expressed in slow muscles (Schoenauer et al.,
2007).
The patterns of expression of myomesin isoforms are highly correlated with
developmental processes and are highly regulated by certain factors. It has been
reported that myomesin-1 and -2 are direct targets of the MEF2C transcription factor
in mice (Matthew et al., 2007).
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Myomesin is capable of binding multiple partners and serves as a docking site
for various proteins. Myomesin-1 binds to myosin in the central region of light
meromyosin and interacts with a single titin Ig domain (Wolfgang et al., 1997). The
muscle-specific creatine kinase interacts with the central domains of myomesin-1 and
myomesin-2 (Hornemann et al., 2003). In addition, myomesin-1 and -3 can form
homodimers using their C-terminal domains (Lange et al., 2005; Pinotsis et al., 2008).
In recent years, structural studies have revealed the importance of myomesin in
force transduction and in maintaining the sarcomeric structure. Based on recently
reported structural studies, myomesin is thought to act as a molecular spring with
adaptable elasticity (Schoenauer et al., 2005; Pinotsis et al., 2012; Tskhovrebova and
Trinick, 2012). In mature fibers, myomesin has high elasticity and can be stretched to
about 2.5 times its original length by unfolding the α-helix linkers (Berkemeier et al.,
2011; Pinotsis et al., 2012). This indicates that myomesin is a highly elastic structure
that maintains sarcomere and M-line organization.
Mutations of certain proteins in the sarcomere can lead to severe defects in
sarcomere organization. Recently, a myomesin mutant was found to be associated
with hypertrophic cardiomyopathy (Siegert et al., 2011). In addition, the protein
abundance of myomesin isoforms may change in disease conditions. The embryonic
heart-specific isoform, EH-myomesin, was shown to be upregulated in some
cardiomyopathies (Agarkova et al., 2000; Schoenauer et al., 2011). This raises the
possibility that myomesin is critical for sarcomere maintenance, and that the isoforms'
change in expression can act as a marker for some myopathies. Consistent with the
importance of myomesin, siRNA-mediated knockdown of myomesin resulted in the
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disruption of sarcomere organization (Fukuzawa et al., 2008). Although there has
been much indirect evidence supporting the idea that myomesin is a pivotal factor in
sarcomere assembly and organization, no knockout models have been reported to
reveal the function of myomesin in vivo, presumably due to the early embryonic
lethality of myomesin mutant mice.
1.1.6 Titin
Titin is the largest protein discovered to date. After myosin and actin, titin is the
third most abundant protein in vertebrate striated muscles (Tskhovrebova and Trinick,
2003). A single titin molecule can stretch from the Z-disc to the M-line. Titin is
largely composed of immunoglobulin-like and fibronectin domains. Fibronectin
domain containing proteins usually have very highly elasticity (Pinotsis et al., 2008).
Thus, one crucial function of titin is to transduce passive forces and stabilize the
sarcomere (Granzier et al., 1997). In addition, titin is involved in some signal
transduction pathways through its M-line localized C-terminal kinase region.
Targeted deletion of M-band titin disrupts sarcomere formation in heart muscles
(Musa et al., 2006).
Titin also has critical functions in sarcomere organization. It was proposed that
titin acts as a molecular ‘ruler’ or blue print for the sarcomere, and that it interacts
with dozens of proteins in the sarcomere from Z-disk proteins at the N-terminal end
to M-band proteins at the C-terminal end (Sanger, J.W. and Sanger, J.M., 2001;
Tskhovrebova and Trinick, 2003). To date, several theories have been proposed for
the function of titin based on biochemical and domain-specific deletion studies;
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however, the detailed mechanism by which titin contributes to sarcomere function
remains to be understood.
1.2 Sarcomere disease
The sarcomere is the basic contractile unit of both skeletal and cardiac muscles.
Defects in sarcomere protein function lead to various muscle diseases in both heart
and skeletal muscles. By 2005, twenty different sarcomeric proteins had been
associated with various skeletal muscle diseases (Laing and Nowak, 2005). Several
types of cardiomyopathies that result from sarcomere protein dysfunction have been
identified in recent clinical studies (Kamisago et al., 2000; Franz et al., 2001; Niimura
et al., 2002). Sarcomere diseases exhibit different severities from mild to early
lethality. Mutations in different proteins can lead to different effects. Some of these
diseases, which affect newborn children, have been demonstrated to be caused by
mutations in sarcomere proteins that are critical for muscle contraction (Laing and
Nowak, 2005). Mutations associated with regulatory proteins in the sarcomere were
shown to increase the probability of cardiac hypertrophy (Laing and Nowak, 2005).
In addition, mutations in sarcomeric proteins that lead to protein misfolding have
been shown to cause a severe disease defined by the failure to transverse force during
the activation of contraction (Kiphuth et al., 2010).
Muscle contraction is generated by the interaction of actin and myosin. Thus,
proper functioning of myosin and actin is critical for normal muscle movement. It has
been shown that mutations in the cardiac isoform of α-actin (ACTC) can cause atrial
septal defects (Matsson et al., 2008) and hypertrophic cardiomyopathy (Mogensen et
al., 1999). Mutations in the skeletal muscle isoform of α-actin (ACTA1) are
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associated with three different muscle diseases: (1) actin myopathy (AM),
characterized by the accumulation of actin filaments in muscle fibers (Laing and
Nowak, 2005), (2) nemaline myopathy (NM) characterized by sarcoplasmic nemaline
bodies (rods) (Sparrow et al., 2003), and (3) intranuclear rod myopathy (IRM)
characterized by the aggregation of actin and α-actinin-2 inside the nucleus of muscle
cells (Domazetovska et al., 2007). In addition to actin-associated diseases, many
myosin-associated sarcomere diseases have also been discovered, such as core-like
lesions, hyaline body myopathy, early onset distal myopathy, dominant inclusion
body myopathy, and distal arthrogryposis trismus-pseudocamptodactyly syndrome
(Laing and Nowak, 2005).
Recently, additional mutations in sarcomeric proteins have been associated with
various kinds of myopathies. However, the pathological mechanisms by which these
mutations cause disease are largely unknown. A better understanding of the
regulation of sarcomere protein organization during muscle cell differentiation will
facilitate a better understanding of disease mechanisms, and is required for the
development of new therapies for sarcomere protein-related myopathies.
1.3 Myofibrillogenesis
Muscle development is a multi-step process that starts with the commitment of
multi-potent mesodermal precursor cells to myoblasts, thus giving rise to the muscle
lineage. This is followed by the differentiation of myoblasts into myocytes and the
fusion of myocytes into multi-nucleated myotubes. The final step of skeletal muscle
formation is the maturation of differentiated myotubes into muscle fibers (McKinsey
et al., 2002; Christ et al., 2002; Buckingham et al., 2003; Du et al., 2008a; Sparrow et
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al., 2009). Muscle fibers are muscle cells that contain dozens of myofibrils.
Myofibrils of skeletal muscles and cardiac muscles are characterized by groups of
proteins arranged in contractile units called sarcomeres. The process of myofibril
assembly into highly organized sarcomeres is called myofibrillogenesis.
1.3.1 Sarcomere assembly
The assembly of myofibril proteins into functional units is a rapid and well-
coordinated process. Structural proteins are critical for the proper assembly of myosin
thick filaments, actin thin filaments, and the organization of sarcomeres. Sarcomere
assembly starts with the formation of small, membrane-associated aggregates called
Z-bodies, which are premature forms of Z-discs (Sparrow et al., 2009). Then, the
maturation of Z-discs leads to the formation of organized sarcomeric structures.
Mature Z-discs are composed of various proteins including α-actinin, the N-terminal
region of titin, and nebulin. Z-discs organize thin actin filaments to form "I-Z-I
brushes". Similarly, the M-lines, which contain the C-terminal of titin, obscurin, and
myomesin, are thought to play key roles in the integration of myosin thick filaments
into the A-band.
Although the basic process of myofibrillogenesis is well characterized, details of
the process of myofibrillogenesis are still open to debate. To date, four models have
been proposed for the process of myofibrillogenesis: (1) the template model, (2) the
independent assembly of thin and thick filaments model, both of which were
proposed by Holtzer and colleagues (Dlugosz et al., 1984; Lu et al., 1992), (3) the
premyofibril model proposed by Sanger and colleagues (Rhee et al., 1994), and (4)
the direct assembly of myofibrils model proposed by Costa and colleagues (Costa et
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al., 2002). The template model proposes that non-muscle proteins must serve as a
temporary template for the formation of a single myofibril due to the inability of
myofibril elements to assemble into mature myofibrils directly (Dlugosz et al., 1984).
The independent assembly of thin and thick filaments model suggests that the I-Z-I
bodies and the thick filaments are first assembled independently of each other, and
then titin molecules join or stitch the scattered I-Z-I bodies and thick filaments
together into elongating mature myofibrils (Lu et al., 1992; Holtzer et al., 1997;
Sanger et al., 2005). The premyofibril model argues that the assembly of the
sarcomere begins with premyofibrils that are composed of mini-sarcomeres whose
boundaries are marked by Z-bodies containing muscle α-actinin. Non-muscle myosin
II filaments are present in the mini-sarcomeres. Z-bodies in the adjacent myofibrils
begin to align into nascent myofibrils. Then, M-band proteins are recruited when the
Z-bodies become mature Z-discs. In the meanwhile, the thick filaments, which
contain muscle specific myosin, align into an A-band (Sanger et al., 2005). The direct
assembly of myofibrils model comes from a report that studied myofibrillogenesis in
zebrafish embryos. The report demonstrated that myofibril assembly is a spontaneous
process with no intermediate stages (Costa et al., 2002). The co-existence of various
models indicates that sarcomere assembly might be a more complicated process than
first predicted due to the structural complexity of the sarcomere.
1.3.2 Myosin assembly
Genetic studies and biochemical analyses have shown that myosin folding and
assembly is an integral part of myofibrillogenesis during muscle development. Recent
studies have indicated that molecular chaperones play important roles in myosin
12
folding and assembly. Unc45b and Hsp90α are key chaperones expressed in skeletal
and cardiac muscles and are thought to play important roles in myosin folding and
sarcomere assembly. The presence of point mutations in and knockdown of unc45b in
zebrafish resulted in a complete lack of motility and myofibril disorganization of both
skeletal and cardiac muscles (Wohlgemuth et al., 2007; Etard et al., 2007). Similarly,
knockdown of hsp90α also exhibited defective motility and sarcomere
disorganization (Hawkins et al., 2008; Du et al., 2008b). Other studies indicated that
Unc45b may regulate myosin filaments by degrading misfolded myosin through a
ubiquitin/proteasome system (Landsverk et al., 2007) or by helping the folding of the
myosin motor domain (Liu et al., 2008). Recent studies indicate that Unc45b and
Hsp90α may interact with each other to form a chaperone-co-chaperone pair that
plays important roles in the assembly of the sarcomere (Etard et al., 2007; Liu et al.,
2008; Srikakulam et al, 2008; Etard et al., 2008). Through powerful molecular and
genetic approaches, additional factors involved in the process of myosin folding and
sarcomere assembly are being identified. For example, our recent studies
demonstrated that Smyd1, a newly identified methyltransferase expressed specially in
skeletal and cardiac muscles, plays a vital role in sarcomere assembly in the skeletal
and cardiac muscles of zebrafish embryos (Tan et al., 2006).
1.4 Smyd1
1.4.1 Smyd1 function in myofibrillogenesis
Smyd1 is a member of the Smyd family of proteins and plays an important role in
muscle development (Gottlieb et al., 2002; Tan et al., 2006). Smyd1 is expressed
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specifically in skeletal and cardiac muscles during embryogenesis and in adult muscle
tissues. The regulation of smyd1 expression in skeletal and cardiac muscles is well
studied. Smyd1 is a direct target of the transcription factors Mef2c and Myod (Park et
al., 2010; Phan et al., 2005). A recent report showed that smyd1 expression is also
regulated by serum response factor (SRF) and by myogenin through direct binding to
the promoter region of Smyd1 (Li et al., 2009). In addition, Smyd1 gene expression
can be repressed by Hepatoma-derived growth factor through interaction with a
transcriptional co-repressor C-terminal binding protein (CtBP) (Yang et al., 2007).
The in vivo function of Smyd1 has been uncovered in recent years. Loss-of-
function studies demonstrated that Smyd1 is essential for embryonic survival in mice
and zebrafish. Smyd1 knockout mouse embryos die around embryonic day 10.5 from
cardiomyogenic defects (Gottlieb et al., 2002). Our recent functional studies in
zebrafish showed that smyd1 is required for myofibrillogenesis in skeletal and cardiac
muscles in zebrafish embryos (Tan et al., 2006; Li et al., 2011). Knockdown of
smyd1b, one of the two smyd1 genes in zebrafish, resulted in myofibril
disorganization in skeletal and cardiac muscles in zebrafish embryos (Tan et al., 2006;
Li unpublished). This was confirmed recently in a zebrafish mutant carrying a
mutation in the smyd1 gene (Just et al., 2011).
At present, little is known about the mechanism by which Smyd1 functions in
myofibrillogenesis. It has been shown that Smyd1 has histone methyltransferase
activity that can methylate histone 3 lysine 4 in vitro (Hamamoto et al., 2004; Tan et
al., 2006). Histone methylation plays a vital role in gene transcriptional regulation,
supporting a potential role for Smyd1 in transcriptional regulation. Several pieces of
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evidence support this view. These include the association of Smyd1 with the skeletal
and heart muscle-specific transcription factor skNAC and the co-localization of
Smyd1 and skNAC in the nucleus of muscle cells early in differentiation (Sims et al.,
2002; Park et al., 2010). In addition, Smyd1 can function as a histone deacetylase
(HDAC)-dependent transcriptional repressor by regulating chromatin modifications
(Gottlieb et al., 2002).
However, arguing against its potential role in transcriptional regulation, Just and
colleagues reported that the Smyd1 mutant lacking histone methyltransferase activity
is biologically active in myofibril assembly (Just et al., 2011). Consistent with its
potential role in the cytosol, little or no nuclear localization of Smyd1 could be
detected during muscle development in zebrafish embryos. In fact, we showed that
Smyd1 is primarily localized in the cytosol of myoblasts and myotubes, followed by
sarcomeric localization (Li et al., 2011). The biological significance of this
sarcomeric localization is currently under investigation. Recent studies have indicated
that members of the Smyd family can also methylate non-histone proteins, raising the
possibility that Smyd1 may have methylation targets in the cytosol of muscle cells.
Smyd1 has been shown to play a regulatory role in myosin assembly when
associated with the Unc45b and Hsp90α complex. A recent report showed that GST-
tagged Smyd1 is capable of specifically pulling down skeletal muscle-specific myosin
heavy chain (Just et al., 2011). In addition, in smyd1 mutant zebrafish embryos,
muscle chaperones hsp90α1 and unc45b were strongly upregulated, indicating a close
relationship among Smyd1, Hsp90α1, and Unc45b (Just et al., 2011). Knockdown of
smyd1 causes an effect similar to that of loss-of-function of hsp90α1 or unc45b,
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resulting in sarcomere disorganization and the degradation of myosin (Landsverk et
al., 2007; Hawkins, et al., 2008; Du et al., 2008b). It has been shown that Hsp90α and
Unc45b shuttle from the Z-line to the A-band under conditions of stress. This
indicates a regulatory role for Hsp90α and Unc45b when myosin homeostasis is
disturbed (Etard et al., 2008). Recent studies by us and others have shown that Smyd1
is localized to the M-line (Li et al., 2011; Just et al., 2011) and that it performs a
similar A-band shuttling (Just et al., 2011). This raises the possibility that the lysine
methyltransferase Smyd1 may play a regulatory role in myosin folding or unfolding
during myofibrillogenesis under conditions of stress. However, the physiological
target protein(s) of Smyd1 have not been identified.
Some recent reports have shown that Smyd2, another member of the Smyd
family, is capable of methylating Hsp90 (Abu-Farha et al., 2011; Donlin et al. 2012).
Methylated Hsp90, Smyd2, and the sarcomere protein titin form a complex, which
contributes to the stability of titin and the sarcomere (Donlin et al. 2012). This finding
raises the question of whether Smyd1 can methylate Hsp90, which is involved in
myosin folding and assembly. To date, several sarcomere proteins, such as myosin,
actin, and creatine kinase have been shown to be methylated at their lysine residues
(Tong and Elzinga, 1983; Iwabata et al., 2005). However, the function of the
methylation of these proteins and the enzyme(s) that drive the methylation events are
still unknown.
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1.4.2 Smyd family lysine methyltransferases
1.4.2.1 Smyd family proteins and histone methylation
Smyd1, as well as other Smyd family proteins, contains the conserved Su(var) 3–
9 (suppressor of position effect variegation), Enhancer of zeste, and Trx (trithorax)
(SET) domain and MYeloid, Nervy, and DEAF-1 (MYND) zinc finger domains,
which are involved in protein methylation and protein-protein interaction,
respectively (Sirinupong et al., 2010). The Smyd subfamily consists of five members,
Smyd1-Smyd5 (Fig. 1). Smyd1, Smyd2, and Smyd3 were shown to be capable of
specifically methylating the lysine sites of histone 3 in vitro and to play important
roles in regulating gene expression and cell proliferation (Hamamoto et al., 2004;
Brown et al., 2006; Tan et al., 2006; Abu-Farha et al., 2008; Kim et al., 2009).
1.4.2.2 Smyd family proteins and non-histone methylation
In addition to histone methylation, it has been demonstrated that Smyd family
proteins are capable of methylating non-histone proteins and play important
regulatory roles. The methylation of non-histone proteins has distinct effects on
protein stability, which can lead to either the stabilization or de-stabilization of the
proteins (Eakin et al., 2007; Yang et al., 2009).
In recent years, several reports have given us a clearer view of the mechanism of
SET domain methyltransferase-mediated non-histone protein methylation. It was a
significant finding that the tumor suppressor p53 and its downstream genes are highly
regulated by Smyd2-mediated methylation (Huang et al., 2006; Xie et al., 2008).
Consistent with the critical functions of non-histone protein methylation in gene
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regulation, myofilament organization has also been shown to be highly regulated by
non-histone protein methylation (Donlin et al., 2012).
1.4.3 Structure of Smyd
Crystal structure studies reveal that Smyd1 is a member of the SET and MYND
family of lysine methyltransferases (Fig. 2). The separated SET domain distinguishes
Smyd proteins from other histone lysine methyltransferases. The SET domain is the
catalytic motif, consisting of about 130 amino acids and sharing a conserved
alpha/beta topology (Jiang et al., 2011). The SET domain is responsible for lysine
methylation and does so by adding methyl groups to lysine residues of proteins using
S-adenosylmethionine (AdoMet) as a donor substrate (Jiang et al., 2011). The MYND
domain is a zinc finger motif that is involved in protein-protein interaction (Liu et al.,
2007). Crystal structure studies reveal that Smyd family proteins also share a helix-
turn-helix structure TPR motif-containing C-terminal domain (CTD) followed by the
SET domain. It was proposed that the CTD domain plays a regulatory role in
modulating the methyltransferase activity of Smyd proteins; however, the detailed
mechanism by which this is achieved is still not well understood (Sirinupong et al.,
2010; Jiang et al., 2011; Sirinupong et al., 2011).
A recent structural and biochemical analysis revealed that Smyd1 has lower
enzymatic activity and weaker histone binding affinity as compared to other histone
methyltransferases (Sirinupong et al., 2010), indicating that Smyd1 may not be
involved in histone methylation. The SET and MYND domain protein family
members (Smyd1-5) share relatively high sequence similarity but exhibit divergence
in their substrate specificity (Xu et al., 2011). The methylation targets of Smyd family
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proteins span various lysine sites on histone 3 and non-histone proteins. It has been
reported that Smyd2 activity can be increased by the binding of Hsp90 (Abu-Farha et
al., 2008), raising the possibility that the interaction of Smyd and Hsp90 may be
involved in the regulation of substrate binding and the enzymatic activity of Smyd
proteins.
1.5 Overview of background information and objectives
Smyd1 is a SET domain-containing protein methyltransferase that is specifically
expressed in skeletal and cardiac muscles. Knockdown or mutation of smyd1 results
in defective myofibril assembly in skeletal and cardiac muscles in zebrafish embryos.
Immunostaining studies reveal that sarcomere organization is completely disrupted in
smyd1b knockdown embryos. Currently, little is known about the mechanism by
which Smyd1 functions. Thus, to better understand the function of Smyd1 in
myofibrillogenesis, the first objective of this work is to characterize the sub-cellular
localization of the two alternatively spliced protein isoforms Smyd1b_tv1 and
Smyd1b_tv2 of Smyd1 using GFP labeled fusion proteins. In addition, we aim to
study the mechanism of Smyd1 function in myofibrillogenesis, specifically, to
determine whether knockdown of smyd1 affects the protein methylation associated
with myofibrillogenesis.
Myomesin is thought to play a critical role in M-band formation and sarcomere
organization. Knockdown of smyd1 results in little or no detectable myomesin M-
line organization. It has been shown that Smyd1 is required for myosin folding and
thick filament assembly. It is not clear whether disruption of myosin thick filament
organization by smyd1 knockdown could indirectly affect M-line formation.
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Alternatively, our preliminary data show that Smyd1 is localized to the M-line,
arguing for a potential role for Smyd1 in M-line organization. Thus, the disruption
of myosin thick filaments and sarcomere organization in smyd1b knockdown
embryos might be due to the loss of M-line proteins, subsequently leading to the
destabilization of sarcomeric organization. The second objective of this study is to
test whether knockdown of myomesin expression results in defective M-line


















Fig. 1. Schematic of five mammalian Smyd proteins. Orange: Split SET domain,
Green: MYND domain, Grey: TPR domain. Positions of amino acids are indicated
behind each sequence.
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Fig. 2. Structure of Smyd1. The rough locations of the split SET domain, MYND domain,
and C- terminal domain, which are represented by orange, green, and grey, respectively, are
presented.
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Chapter 2: Smyd1b_tv1 is localized to the M-line of skeletal
muscle fibers
2.1 Abstract:
Smyd1b is a member of the Smyd family proteins and plays a key role in
sarcomere assembly during myofibrillogenesis. smyd1b encodes two alternatively
spliced protein isoforms, Smyd1b_tv1 and Smyd1b_tv2. To better understand the
function of Smyd1b in myofibrillogenesis, we analyzed the sub-cellular localization
of Smyd1b_tv1 and Smyd1b_tv2 in transgenic zebrafish by expressing Smyd1b_tv1-
EGFP and Smyd1b_tv2-EGFP fusion proteins. Smyd1b_tv1 and Smyd1b_tv2 were
primarily localized in the cytosol of myoblasts and myotubes in early stage zebrafish
embryos. However, in mature myofibers of late stage embryos, Smyd1b_tv1, and to a
small degree of Smyd1b_tv2, exhibited sarcomeric localization. Immunostaining with
sarcomeric markers revealed that Smyd1b_tv1 was localized to the M-line.
Smyd1b_tv1 differs from Smyd1b_tv2 by a 13-amino acid (aa) insertion encoded by
the tv1-specific exon 5, suggesting that some residues within the 13 aa insertion may
be critical for the strong sarcomeric localization of Smyd1b_tv1. Comparison of the
zebrafish Smyd1b_tv1 sequence with that of orthologs from other vertebrates
revealed several highly conserved residues (Phe223, His224, and Gln226) and two
potential phosphorylation sites (Thr221 and Ser225) within the 13 aa insertion. To
determine whether these residues are involved in the sarcomeric localization of
Smyd1b_tv1, we mutated these residues individually into alanine. Substitution of
Phe223 or Ser225 with an alanine residue significantly reduced the sarcomeric
localization of Smyd1b_tv1. In contrast, other substitutions (His224 and Gln226) had
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no effect. Moreover, replacing Ser225 with a threonine residue (S225T) retained the
strong sarcomeric localization of Smyd1b_tv1. Together, these data indicate that
Phe223 and Ser225 are required for the M-line localization of Smyd1b_tv1.
2.2 Introduction:
Smyd1, also known as m-Bop, represents a recently identified SET domain
containing protein methyltransferase that is specifically expressed in skeletal and
cardiac muscles. It plays critical roles in myofiber maturation and contraction (Tan et
al., 2006). Targeted deletion of Smyd1 in mice leads to embryonic lethality at
embryonic day (ED) 10.5 (Gottlieb et al., 2002). Knockdown or mutation of smyd1 in
zebrafish leads to defective myofibrillogenesis and the disruption of the sarcomere
(Tan et al., 2006; Just et al., 2011).
It has been suggested that Smyd1 functions as a transcriptional repressor that is
dependant upon HDAC activity (Gottlieb et al., 2002). Further biomedical studies
have revealed that Smyd1 can methylate histone 3 lysine 4 in vitro (Tan et al., 2006).
Consistent with its potential roles in transcriptional regulation, Smyd1 colocalizes
with a transcription factor called skNAC in the nucleus of C2C12 differentiated
myoblast cells (Sims et al., 2002). However, our previous data using a myc-tagged
protein showed the cytoplasmic localization of Smyd1b in the myofibers of zebrafish
embryos, indicating potential roles for Smyd1b in the cytoplasm.
The smyd1b gene encodes two alternatively spliced protein isoforms in zebrafish
that are named Smyd1b_tv1 and Smyd1b_tv2. Smyd1b_tv1 differs from Smyd1b_tv2
in that it contains a 13 amino acid insertion encoded by the tv1-specific exon 5.
Functional analysis revealed that both smyd1b_tv1 and smyd1b_tv2 isoforms are able
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to rescue the thick filament defect caused by smyd1b knockdown (Tan et al., 2006). It
is not clear whether the two isoforms may have distinct localization and functions. A
better characterization of the sub-cellular localization of Smyd1b_tv1 and
Smyd1b_tv2 is critical for uncovering their potential functional specificity, and for
gaining a mechanistic understanding of Smyd1b function in regulating muscle cell
differentiation.
In this study, we generated transgenic zebrafish expressing EGFP tagged
Smyd1b_tv1 and Smyd1b_tv2. We show that Smyd1b_tv1 and Smyd1b_tv2 are
primarily localized in the cytosol of the myoblasts and myotubes of early stage
zebrafish embryos. However, Smyd1b_tv1 exhibits sarcomeric localization in mature
fibers in late stage embryos. Further studies reveal strong localization of Smyd1b_tv1
to the M-line. This strong M-line localization is dependant on the presence of the
Phe223 and Ser225 residues unique to the additional 13 aa in Smyd1b_tv1.
2.3 Materials and Methods:
2.3.1 Construction of Tol2-Smyd1b_tv1-EGFP, Tol2-Smyd1b_tv2-EGFP
pTol2-Smyd1b_tv1-EGFP and pTol2-Smyd1b_tv2-EGFP constructs were
generated by cloning the smyd1b_tv1 and smyd1b_tv2 coding sequences in-frame
upstream of the EGFP coding sequence in the Tol2 vector. Briefly, the smyd1b_tv1
and smyd1b_tv2 coding sequences without the stop codon were amplified by PCR
using Pfu DNA polymerase (Stratagene, Santa Clara, CA, USA) from DNA plasmids
Smyd1-Smyd1bmyc_tv1 and Smyd1-Smyd1bmyc_tv2 using the following primers:
Smyd1b-F (5'-CGGGATCCATGGAGTTTGTGGAAGTTTTTGA-3') and Smyd1b-R
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(5'-CGGGATCCTTCCTGCGGAACAGGTTCTTGAT-3'). BamHI sites was
introduced at the 5' and 3' ends of the Smyd1b_tv1 or Smyd1b_tv2 coding sequences
via the PCR primers. The PCR products were digested with BamHI and then cloned
into the BamHI site of the T2A200R150G vector (Urasaki et al., 2006). The DNA
sequence at the Smyd1b and EGFP junction was confirmed by sequencing.
2.3.2 Mutagenesis
To generate Smyd1b_tv1-EGFP constructs with S217A, S225A, S225T, 225D,
T221A, F223A, H224A or Q226A mutations, we carried out the mutagenesis using
the QuikChange site-directed mutagenesis kit (Stratagene). The Smyd1-Smyd1b_tv1-
EGFP plasmid was used as the DNA template. The following PCR primers were used:
S217A + T221A-f: 5'-AATCAGGCGGCCATCGATGCTGTGTTT-3'














2.3.3 Generation and maintenance of transgenic zebrafish lines
Mature zebrafish were raised at the Zebrafish Facility of the Aquaculture
Research Center, Institute of Marine and Environmental Technology. The fish were
maintained at 28°C with a photoperiod of 14 h of light and 10 h in the dark in 8-
gallon aquaria supplied with fresh water and aeration. For the generation of
transgenic fish lines, ef1α-Smyd1b_tv1-EGFP and ef1α-Smyd1b_tv2-EGFP
constructs were constructed by cloning the cDNA encoding the EGFP-tagged
Smyd1b_tv1 or EGFP-tagged Smyd1b_tv2 downstream of the EF1a promoter in the
Tol2 vector. The ef1α-Smyd1b_tv1-EGFP and ef1α-Smyd1b_tv2-EGFP constructs
were microinjected into zebrafish embryos as described (Xu et al., 2012). Germ-line
transgenic founders were identified from F1 embryos by screening with fluorescent
microscopy (Zeiss, Oberkochen, Germany) at 24 hours post fertilization (hpf).
2.3.4 Immunostaining of whole-mount fish embryos
Immunostaining was carried out using whole-mount zebrafish embryos with
the anti-MyHC antibody (F59 antibody) and anti-α-actinin antibody. Secondary
antibodies were FITC or TRITC-conjugates (Sigma). The embryos were
photographed under an upright microscope (Zeiss, Oberkochen, Germany) equipped




2.4.1 Characterization of Smyd1b_tv1 and Smyd1b_tv2 sub-cellular
localization in the myofibers of zebrafish embryos expressing the EGFP
fusion protein
It has been reported that Smyd1 is first localized to the nucleus of C2C12
myoblasts, followed by strong localization in the cytoplasm of differentiated
myotubes (Sims et al., 2002). In zebrafish, smyd1b encodes two alternatively spliced
protein isoforms, Smyd1b_tv1 and Smyd1b_tv2, which are expressed in skeletal and
cardiac muscles (Tan et al., 2006). Smyd1b_tv1 differs from Smyd1b_tv2 by the
presence of a 13 amino acid insertion encoded by the Smyd1_tv1-specific exon 5 (Fig.
3). To better understand Smyd1b function in myofibril assembly, we analyzed the
sub-cellular localization of Smyd1b_tv1 and Smyd1b_tv2 during muscle development
in zebrafish embryos via transient expression of their EGFP fusion proteins by DNA
injection. The DNA constructs pTol2-Smyd1b_tv1-EGFP and pTol2-Smyd1b_tv2-
EGFP expressing the EGFP-tagged Smyd1b_tv1 and Smyd1b_tv2 fusion proteins,
respectively, (Fig. 4A) was injected into fertilized zebrafish eggs at the 1–2 cell stage.
In addition, the biological activities of these EGFP fusion proteins were confirmed by
a rescue assay in zebrafish embryos. The rescue assay was performed by co-injecting
smyd1b morpholino (MO) with the pTol2-Smyd1b_tv1-EGFP or pTol2-Smyd1_tv2-
EGFP DNA constructs. The data revealed that Smyd1b_tv1-EGFP and Smyd1b_tv2-
EGFP fusion proteins were biologically active (Fig. 4B–G). In the rescue experiment,
a clear thick filament organization was detected in a mosaic pattern in the co-injected
embryos, consistent with the mosaic pattern of Smyd1b_tv1-EGFP and Smyd1b_tv2-
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EGFP expression. Moreover, clear sarcomeric localization was detected for
Smyd1b_tv1-EGFP but not for Smyd1b_tv2-EGFP in 48 hpf embryos (Fig. 4B and
C).
To further characterize the sub-cellular localization of Smyd1b_tv1 and
Smyd1b_tv2 during development, the pTol2-Smyd1b_tv1-EGFP and pTol2-
Smyd1b_tv2-EGFP DNA constructs were separately injected into zebrafish embryos
at the 1–2 cell stage. The injected embryos were fixed at 48 hpf and 96 hpf.
Smyd1b_tv1-EGFP exhibited clear sarcomeric localization at both 48 hpf and 96 hpf
(Fig. 5A and D). However, Smyd1b_tv2-EGFP showed weaker sarcomeric
localization as compared to Smyd1b_tv1-EGFP (Fig. 5B and E).
2.4.2 Characterization of the sub-cellular localization of Smyd1b_tv1 and
Smyd1b_tv2 in transgenic zebrafish embryos
To further confirm the sub-cellular localization of Smyd1b_tv1 and Smyd1b_tv2,
two transgenic zebrafish lines expressing EGFP-tagged Smyd1b_tv1 or EGFP-tagged
Smyd1b_tv2 under the control of the EF-1α promoter were generated. Rescue studies
revealed that expression of the smyd1b_tv1-EGFP and smyd1b_tv2-EGFP transgenes
was sufficient to rescue the loss of endogenous Smyd1b expression induced by
morpholino knockdown, indicating that the Smyd1b_tv1-EGFP and Smyd1b_tv2-
EGFP fusion proteins from the transgenes were biological active (Fig. 6). We next
examined the sub-cellular localization of Smyd1b_tv1-EGFP and Smyd1b_tv2-EGFP
in zebrafish embryos at different stages of development. The results showed dynamic
sub-cellular localization of Smyd1b_tv1-EGFP and Smyd1b_tv2-EGFP during
muscle development. In the early developmental stage around 22 hpf, Smyd1b_tv1-
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EGFP and Smyd1b_tv2-EGFP were primarily localized in the cytosol with little or no
nuclear localization (Fig. 7A and B). As development proceeded, sarcomeric
localization of Smyd1b_tv1-EGFP was observed in the first batch of mature
myofibers in zebrafish embryos around 24–27 hpf (Fig. 7C and E). As more fibers
matured during development, sarcomeric localization was observed in additional
myofibers of late stage 48 and 72 hpf embryos (Fig.7G and I). In contrast, only weak
sarcomeric localization could be detected for Symd1b_tv2-EGFP at 48 and 72 hpf
(Fig. 7H and J).
2.4.3 Smyd1b_tv1 is localized to the M-line of sarcomeres
To better define the sarcomeric localization of Smyd1b_tv1 and Smyd1b_tv2,
we analyzed the sub-cellular localization of Smyd1b_tv1-EGFP in zebrafish embryos
expressing a myomesin-3-RFP fusion protein at the M-line. The myomesin-3-RFP
expressing line was obtained from Ekker's lab (Clark et al., 2011). Myomesin-3 is the
major component of the sarcomeric M-line structure in slow muscles. Thus,
myomesin-3-RFP expression represents the M-line structure. The pTol2-
Smyd1b_tv1-EGFP construct was microinjected into myomesin-3-RFP expressing
zebrafish embryos at the 1–2 cell stage. The sarcomeric localization of Smyd1b_tv1-
EGFP (green) and myomesin-3-RFP (red) was determined by confocal microscopy at
96 hpf. Clear co-localization of Smyd1b_tv1-EGFP and myomesin-3-RFP was
observed (Fig. 8A, C, and E). Moreover, co-staining with anti-Myosin Heavy Chain
(MHC) antibody revealed that Smyd1b_tv1-EGFP was localized in the middle of the
A-bands (Fig. 8B, D, and F), consistent with M-line localization. Together, these data
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indicate that Smyd1b_tv1 is localized to the M-line of skeletal muscles, and thus may
be involved in M-line organization.
2.4.4 Phe223 and Ser225 are critical for the M-line localization of
Smyd1b_tv1
Several conserved residues were identified within the 13 aa insertion specific to
Symd1b_tv1. These include three potential phosphorylation sites at Ser217, Thr221,
and Ser225 (Fig. 9A). To test directly whether these three residues are required for
the sarcomeric localization of Smyd1b_tv1, substitutions were made in the DNA
sequences encoding these residues by replacing the sequences with sequences
encoding alanine residues in the pTol2-Smyd1b_tv1-EGFP expression construct. The
mutant proteins were expressed in zebrafish embryos by DNA microinjection. The
sub-cellular localization of these Smyd1b_tv1-EGFP mutant proteins was carefully
examined in the injected zebrafish embryos under a confocal microscope. Previous
studies in our lab have shown that the substitution of Ser217 and Thr221 with alanine
has no effect on the sarcomeric localization of Smyd1b_tv1S217A+T221A (Li et al.,
2011). However, the substitution of Ser225 with alanine abolished the sarcomeric
localization of Smyd1b_tv1S225A-EGFP (Fig. 9C). Together, these results indicate
that Ser225 is required for the sarcomeric localization of Smyd1b_tv1.
Sequence comparison revealed that Ser225 is replaced by threonine in the chick,
mouse, and human orthologs of Smyd1b_tv1 (Fig. 9A). Serine and threonine are
similar amino acids in that they are potential sites for post-translational modification
by phosphorylation or glycosylation. To determine whether the substitution of Ser225
with threonine (S225T) has an effect on the sarcomeric localization of Smyd1b_tv1,
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we generated the Smyd1b_tv1S225T-EGFP mutant and analyzed its sub-cellular
localization in zebrafish embryos. The result showed that the S225T substitution had
no effect on the sarcomeric localization of Smyd1b_tv1S225T-EGFP (Fig. 9D). To
determine whether the potential phosphorylation of Ser225 could be involved in the
sarcomeric localization of Smyd1b_tv1, we substituted Ser225 with aspartic acid
(S225D). It has been reported that the substitution of serine residues with aspartic
acid mimics serine phosphorylation (Leger et al., 1997; Saad et al., 2007). Our result
showed that the S225D substitution abolished the sarcomeric localization of
Smyd1b_tv1S225D-EGFP (Fig. 9E), indicating that post-translational modification
by phosphorylation may not be involved in the sarcomeric localization of
Smyd1b_tv1. The S225A substitution might lead to a change in protein structure,
masking or changing the translocation signal required for its M-line localization. To
evaluate the possibility that the highly conserved amino acids surrounding Ser225
might be involved in M-line localization, we mutated additional aa residues at F223,
H224 and Q226. We observed that mutation of the conserved Phe223 (F223) residue
dramatically diminished the M-line localization of the mutant protein (Fig. 9F). By
contrast, mutating the two other conserved residues (H224, Q226) had no effect on
protein localization (Fig. 9G and H). Collectively, these data indicate that Phe223 and
Ser225 are required for the sarcomeric localization of Smyd1b_tv1. The S225A and
F223A substitutions might lead to a change in protein structure that masks or changes




In this study, we analyzed the sub-cellular localization of Smyd1b_tv1 and
Smyd1b_tv2 during muscle development in zebrafish embryos. We found that
Smyd1b_tv1 and Smyd1b_tv2 were primarily localized in the cytosol in early stage
embryos. However, they showed sarcomeric localization in differentiated myofibers.
Compared with Smyd1b_tv2, Smyd1b_tv1 showed stronger sarcomeric localization,
and the sarcomeric localization was restricted to the M-line. The Phe223 and Ser225
residues, which are located within the Smyd1b_tv1-specific 13 aa insertion, are
necessary for the sarcomeric localization of Smyd1b_tv1.
2.5.1 Sarcomeric localization of Smyd1b_tv1 and Smyd1b_tv2 in
myofibers
Recent studies have indicated potential roles for Smyd1 in regulating gene
transcription in the nucleus. It has been reported that Smyd1 might act as an HDAC-
dependent repressor in vitro (Gottlieb et al., 2002). Biochemical studies indicate that
Smyd1 is capable of interacting with the transcription factor skNAC (Sims et al.,
2002; Park et al., 2010). Although Smyd1 was found to be initially localized in the
nucleus of C2C12 cells, it was later found to translocate to the cytoplasm (Sims et al.,
2002). In this study, we found that both isoforms of Smyd1b are primarily localized
in the cytosol at early developmental stages of zebrafish embryos. No nuclear
localization of Smyd1b could be detected. Instead, we found that Smyd1b_tv1
exhibited strong sarcomeric localization. Co-staining with sarcomere specific markers
revealed that Smyd1b_tv1 was localized to the M-line. Our findings are consistent
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with a recent report by Just and colleagues showing the M-line localization of
Smyd1b_tv1 in zebrafish skeletal muscles (Just et al., 2011). Due to the critical role
of the M-line in sarcomere organization, the M-line localization of Smyd1b_tv1
might have important biological functions.
Despite the different extents of M-line localization of Smyd1b_tv1 and
Smyd1b_tv2, both isoforms were able to rescue the loss of Smyd1b function induced
by morpholino knockdown (Tan et al., 2006). Sequence analysis revealed that both
isoforms contain a potential myosin binding region located at the C-terminal end of
the protein. A biomedical study showed that Smyd1b-GST was capable of binding to
myosin in a pull down assay (Just et al., 2011). Interestingly, an M-line to A-band
shuttling event was observed for Smyd1b_tv1 under conditions of stress (Just et al.,
2011). Strikingly, similar A-band shuttling events have been found for Hsp90α and
Unc45b, which are molecular chaperones involved in myosin folding and assembly
(Etard et al., 2008). Together, these data indicate that Smyd1b may play an important
role in myofibrillogenesis by regulating myosin assembly.
Recent studies have also revealed that some non-histone proteins can be
methylated by Smyd family members. The methylation of the non-histone proteins
play important roles in protein stability (Huang et al., 2006; Donlin et al., 2012). We
speculate that Smyd1b can methylate structural or regulatory proteins that are
involved in sarcomere assembly and stability and are found at the M-line or A-band.
However, the direct target(s) of Smyd1b remains to be determined.
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2.5.2 Regulation of sarcomere localization by Phe223 and Ser225
In this study, we showed that Smyd1b_tv1 exhibits greater M-line localization
than Smyd1b_tv2 in mature myofibers. The enhanced M-line localization of
Smyd1b_tv1 requires Phe223 and Ser 225. Substitution of Phe223 or Ser225 with
alanine significantly reduced the M-line localization of Smyd1b_tv1 to a level similar
to that of Smyd1b_tv2. Sequence analysis indicated that Ser225 of Smyd1b_tv1 could
be a potential phosphorylation site. Phosphorylation is a common post-translational
modification involved in the regulation of protein sub-cellular localization. Consistent
with the potential regulation of Smyd1b by phosphorylation of Ser225, substitution of
serine with the amino acid threonine, which is also commonly phosphorylated, did
not affect the M-line localization of Smyd1b_tv1S225T. However, substitution of
Ser225 with aspartic acid, which mimics phosphorylation, significantly reduced the
M-line localization of Smyd1b_tv1S225D. These data indicate that the M-line
localization of Smyd1b_tv1 might not result from the phosphorylation of Ser225. An
alternative explanation is that the Ser225 and Phe223 residues are critical amino acids
for maintaining protein conformation. Structural analysis revealed that Ser225 and
Phe223 are located in the core SET domain (Sirinupong et al., 2010). The substitution
of Ser225 or Phe223 might lead to decreased enzyme activity or reduced binding
affinity to target proteins.
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Fig. 3. Schematic representation of Smyd1b_tv1 and Smyd1b_tv2. smyd1b_tv1 and
smyd1b_tv2 transcripts are generated by alternative splicing. Their cDNA sequences are
identical, with the exception of a 39 bp insertion encoded by exon 5. Exon 5 translates














Fig. 4. Rescue of the myofibril organization defect in smyd1b knockdown
embryos by the expression of Smyd1b_tv1-EGFP or Smyd1b_tv2-EGFP fusion
proteins.
A. DNA constructs encoding Smyd1b_tv1-EGFP fusion protein, Smyd1b_tv2-
EGFP fusion protein, or EGFP were generated and injected into zebrafish embryos.
B and C. Myofibers expressing Smyd1_tv1-EGFP (B) or Smyd1_tv2-EGFP (C)
were directly observed under fluorescence.
D and E. Myosin thick filament organization was determined by F59 antibody
staining in Smyd1_tv1-EGFP (D) and Smyd1_tv2-EGFP (E) co-injected embryos.
F and G. Double staining showing the colocalization of normal fibers, which are


































Fig. 5. Characterization of sarcomeric localization using Smyd1b_tv1-EGFP
and Smyd1b_tv2-EGFP fusion proteins. DNA constructs encoding Smyd1b_tv1-
EGFP fusion protein, Smyd1b_tv2-EGFP fusion protein, or EGFP were injected into
zebrafish embryos. Protein expression and localization were determined in myofibers
of the injected zebrafish embryos at 48 hpf (A–C) and 96 hpf (D–F).
A and D, Smyd1b_tv1-EGFP;
B and E, Smyd1b_tv2-EGFP;
C and F, EGFP control.
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α-actinin antibody staining(red)
F59 (MyHC) antibody staining(red)
F59 (MyHC) antibody staining(red)






















Fig. 6. Rescue of the myofibril





A–F. Rescue of the myofibril
organization defect caused by
smyd1b knockdown in
Smyd1b_tv1-EGFP transgenic
fish. Sarcomere organization was
examined by α-actinin antibody
staining (A–C) and F59 (MyHC)
staining (D–F).
G–L. Rescue of the myofibril
organization defect caused by
smyd1b knockdown in
Smyd1b_tv2-EGFP transgenic
fish. Sarcomere organization was
examined by α-actinin antibody
staining (G–I) and F59 (MyHC)
staining (J–L).
M–R. Defective myofibril
organization in WT fish embryos
results from smyd1b knockdown.
Sarcomere organization was
examined by α-actinin antibody







































A and B. Cytosolic








seen at 24 hpf (C) and was
enhanced by 27 hpf (E).
Sarcomeric localization of
Smyd1b_tv2-EGFP could
not be detected at 24 hpf (D)
or 27 hpf (F).
G–K. Strong sarcomeric
localization of Smyd1b_tv1-
EGFP was exhibited in 48
hpf (G) and 72 hpf (I)
embryos. No or weak
sarcomeric localization of
Smyd1b_tv2-EGFP could be







Fig. 8. Smyd1b_tv1-EGFP is localized to the M-line of zebrafish skeletal
muscles.
The smyd1b_tv1-EGFP construct was injected into myomesin-RFP (A, C, and E) or
wild type (B, D, and F) zebrafish embryos at the 1–2 cell stage. Smyd1b_tv1-EGFP
localization was determined together with that of an M-line marker (myomesin-RFP)
and an A-band marker (myosin heavy chain (MyHC)) at 96 hpf.
A, C, and E. Co-localization of Smyd1b_tv1-EGFP and myomesin-RFP was
observed in the myofibers of the injected embryos.
B, D, and F. Immunostaining with anti-MyHC antibody (F59) showed the
localization of Smyd1b_tv1-EGFP in the middle of the A-bands of myofibers in
zebrafish embryos
FE Double 96h Double 96h
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Fig. 9. Effect of S225A, S225T, S225D, F223A, H224A, and Q226A substitution
on the sarcomeric localization of Smyd1b_tv1-EGFP in zebrafish embryos. DNA
constructs expressing Smyd1b_tv1-EGFP or its derived mutants S225A, S225T,
S225D, F223A, H224A, and Q226A were injected into zebrafish embryos. Their
localization was analyzed in the myofibers of the injected embryos at 48 hpf.
A. Sequence comparison shows the alternative splicing of smyd1b in various
vertebrates and the conserved serine and threonine residues within the 13 aa insertion.
B. Smyd1_tv1-EGFP; C, Smyd1_tv1-EGFP (S225A); D, Smyd1_tv1-EGFP (S225T);
E, Smyd1_tv1-EGFP (S225D); F, Smyd1_tv1-EGFP (F223A); G, Smyd1_tv1-EGFP
(H224A); and H, Smyd1_tv1-EGFP (Q226A).
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Chapter 3: Expression and functional analysis of myomesins
in myofibrillogenesis in zebrafish embryos
3.1 Abstract:
Myofibrillogenesis, the process of sarcomere formation, requires the close
interaction and collaboration of sarcomeric proteins and various sarcomeric structures.
The M-line structures are key components of sarcomeres and play a vital role in
myofibrillogenesis and sarcomere organization. It has been suggested that myomesin,
which is present on the M-line, interacts with myosin proteins and keeps the myosin
filament in order (Obermann et al., 1997). However, the role of myomesin in
myofibrillogenesis and sarcomere organization has not been elucidated in vivo. In this
study, we classified the members of the myomesin gene family and analyzed the
temporal and spatial expression pattern of each isoform. We carried out a loss-of-
function analysis of the myomesin isoforms myomesin-3, which is specifically
expressed in the slow muscles of zebrafish embryos, and myomesin-1b, which is
highly expressed both in cardiac and skeletal muscles. We demonstrate that
knockdown of neither isoform has any effect on the sarcomeric organization of M-
lines or other sarcomere structures including the thick and thin filaments and the Z-
disc. Together, these studies indicate that myomesin-1b and myomesin-3 are
dispensable for sarcomere organization and M-line formation.
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3.2 Introduction:
The sarcomere, the basic contractile unit of skeletal and cardiac muscles, is one
of the most highly ordered macromolecular assemblies in cells. The sarcomere can be
divided into four major compartments: the Z-disc, M-lines, thick filaments, and thin
filaments. The M-band, which is thought to crosslink the myosin filaments, plays
pivotal roles in sarcomere organization and in the assembly of highly organized thick
and thin filaments. The muscle-specific protein myomesin, which is one of the most
abundant components of the M-line, is a major candidate thought to mediate the role
of M-line bridges in regulating the packaging of thick filaments and in uniformly
distributing tension over the myosin filament lattice in activated sarcomeres
(Agarkova et al., 2003).
According to the current M-line model, neighboring myosin filaments are
connected by myomesin molecules that bind with their N-terminal domains to the
myosin rod (Obermmann et al., 1997; Auerbach et al., 1999), and dimerize in an
antiparallel fashion via their C termini (Lange et al., 2005). In addition, myomesin
can bind tightly to the C-terminal end of the titin string extending into the M-line.
As shown in Chapter 2, Smyd1b_tv1 localizes to the M-line. Consistent with its
potential function in M-line organization, little or no organized myomesin could be
detected in smyd1b knock-down embryos by immunostaining (Li et al., unpublished
data). However, other key sarcomere structures, including the thick and thin filament
as well as the Z-line were disrupted in the smyd1b knockdown embryos. This raises
the question of whether the disruption of other sarcomere structures in smyd1b
knockdown embryos is an indirect effect of the disruption of myosin thick filaments
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leading to defective M-line organization, or whether it is due to the direct disruption
of myomesin organization. Thus, a loss-of-function study could provide important
insight into whether inhibiting myomesin expression directly, could result in myofibril
defects similar to those seen upon smyd1 knockdown. However, no knockout models
have been generated as yet for myomesin due to potential early embryonic lethality.
Although RNAi-mediated knockdown of myomesin disrupts the M-band structure
leading to sarcomeric disorganization in cultured neonatal rat cardiomyocytes
(Fukuzawa et al., 2008), the function of myomesin in sarcomere organization is yet to
be analyzed in vivo.
In this study, we identified 5 myomesin genes in zebrafish and analyzed their
patterns of expression during development. We specifically knocked down myomesin-
1b and myomesin-3 in zebrafish and analyzed the muscle phenotype in these fish in
terms of sarcomere organization and M-line localization of Smyd1b_tv1. We
demonstrate that the knockdown of neither myomesin-1b nor myomesin-3 has any
effect on sarcomere organization. On the contrary, the knockdown of hsp90α1 and
unc45b, which are thought to be involved in myosin folding, severely disrupts M-line
organization.
3.3 Materials and Methods:
3.3.1 Time-course Reverse Transcriptase (RT)-PCR
Total RNA was extracted from zebrafish embryos at 0, 3, 6, 9, 12,14, 19, and 24
hpf and 2, 3, 4, 5, and 6 days post fertilization (dpf) using TRIZOL (Ambion, NY,
USA) according to the manufacturer's instructions. Extracted RNA was converted to
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cDNA using the RevertAid First Strand cDNA Synthesis Kit (Fermentas, MD, USA).
myomesin1a/1b/2a/2b/3 were amplified using the primer pairs MyoM1a-
FP1/MyoM1a-RP1, MyoM1b-FP1/MyoM1b-RP1, MyoM2a-FP1/MyoM2a-RP1,
MyoM2b-FP1/MyoM2b-RP1, and MyoM3-FP1/MyoM3-RP1, respectively.













3.3.2 Whole-mount in situ hybridization
Whole-mount in situ hybridization was carried out using digoxigenin-labeled
antisense probes. The fragments for probes were generated by PCR amplification
using the primers discussed above (Time-course RT-PCR section). The PCR
products were purified and cloned into pGEM-T Easy vectors (Promega, WI, USA)
to generate the pGEM-myomesin1a-probe, pGEM-myomesin1b-probe, pGEM-
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myomesin2a-probe, pGEM-myomesin2b-probe, and pGEM-myomesin3-probe
plasmids. pGEM-myomesin1a/1b/2b/3-probes were linearized with NcoI, and
pGEM-myomesin2a-probe was linearized with SphI. pGEM-myomesin1a/1b/2b/3-
probes and pGEM-myomesin2a-probe were transcribed with SP6 and T7 RNA
polymerases, respectively. These antisense probes hybridize with specific isoforms
of myomesin mRNA transcripts because the sequences in the 3'UTR used for
making antisense probes are highly diverse among the different isoforms of
myomesin genes.
3.3.3 Immunostaining of whole-mount fish embryos
Immunostaining was carried out using whole-mount zebrafish embryos with
the following antibodies: anti-actinin, anti-MyHC for slow muscles, anti-myomesin,
and anti-actin. Secondary antibodies were FITC or TRITC-conjugates (Sigma, MO,
USA). The embryos were photographed under an upright microscope (Zeiss)
equipped with a confocal image analyzer (Bio-Rad Radiance 2100 Imaging Systems;
Bio-Rad, CA, USA).
3.3.4 Synthesis of morpholino-modified antisense oligos
Morpholino (MO) antisense oligos were synthesized by Gene Tools (Carvalis,
OR, USA). The translational blockers (Unc-45b-ATG-MO, Hsp90α1-ATG-MO, and
Myomesin-3-ATG-MO) were devised based on the sequence near the ATG start site.
The splice blocking morpholinos Myomesin-1b-MO1 and Smyd1b-E9I9-MO1 were






Unc-45b-ATG-MO: 5’ -ATCTCCAATTTCTCCCATCGTCATT- 3’
Hsp90α1-ATG-MO: 5’-CGACTTCTCAGGCATCTTGCTGTGT-3’.
3.3.5 Microinjection in zebrafish embryos
Morpholino antisense oligos were dissolved in 1X Danieau buffer to a final
concentration of 0.5 mmol/L or 1 mmol/L. DNA plasmids were dissolved in water at
50 ng/mL. Approximately 1–2 nL (5 ng or 10 ng) was injected into each zebrafish
embryo at the 1–2 cell stage. For morpholino and DNA co-injection, morpholino (1
mM) and DNA (100 ng/mL) were mixed at a 1:1 ratio and 1–2 nL of the mixture was
injected into zebrafish embryos at the 1–2 cell stage.
3.3.6 Morpholino efficiency analysis
To determine the effect of Myomesin-1b-MO1 on splicing, total RNA was
extracted from WT and MO-injected embryos at 48 hpf using TRIZOL (Ambion)
according to the manufacturer's instructions. Extracted RNA was converted to
cDNA using the RevertAid First Strand cDNA Synthesis Kit (Fermentas). The
myomesin-1b transcript was amplified by RT-PCR using the primers, MyoM1bRT-





3.4.1 Identification of myomesin gene family members in zebrafish
In mammals, three isoforms of myomesin that exhibit distinct expression patterns
in cardiac and skeletal muscles were identified. It is well known that the zebrafish
genome contains duplicated genes. Zebrafish often have two copies of a gene that is
present as a single copy in mammals. In order to identify the myomesin genes in
zebrafish, myomesin orthologs were obtained from the National Center for
Bioinformatics (NCBI) by blasting the coding sequences of human and mouse
myomesin isoforms against zebrafish genome.
We showed that there are at least five myomesin genes expressed in the zebrafish.
Zebrafish Zfmyomesin-1a (GeneID: 558671), together with Zfmyomesin-1b (GeneID:
100144770), which encodes two alternatively spliced mRNA isoforms named
Zfmyomesin1b_tv1, Zfmyomesin1b_tv2, is an ortholog of the human and mouse
Myomesin-1. Through EST and genome analyses, two predicted Zfmyomesin-2-like
sequences named Zfmyomesin-2-like-1 (GeneID: 100538326) and Zfmyomesin-2-like-
2 (GeneID: 568460) were shown to be part of the same gene and could be linked
together by EST analysis. To confirm this result, we amplified a sequence using a
forward primer that was located 3' of Zfmyomesin-2-like-1 and a reverse primer
located 5' of Zfmyomesin-2-like-2. Sequencing of the RT-PCR product showed that
Zfmyomesin 2-like-1 and Zfmyomesin 2-like-2 yielded a single sequence as we
predicted. The new Zfmyomesin-2-like sequence was named Zfmyomesin-2a. A newly
identified gene wu:fi38e05 (GeneID: 334269), which was named Zfmyomesin-2b, was
confirmed as a homolog of Zfmyomesin-2a. Finally, the Zfmyomesin-3 (GeneID:
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559614) sequence was confirmed by RT-PCR. Multiple-alignment analysis showed
that the five myomesin genes in zebrafish are highly conserved. A phylogenetic tree
was constructed that revealed a clear relationship among the different orthologs when
compared with the mouse and human myomesin genes (Fig. 10). Together, these data
indicate that there are at least five myomesin genes in zebrafish: Zfmyomesin-1a,
Zfmyomesin-1b, Zfmyomesin-2a, Zfmyomesin-2b, and Zfmyomesin-3.
3.4.2 Temporal and spatial expression patterns of myomesin genes in
zebrafish embryos
The temporal expression pattern of the myomesin genes in zebrafish was
determined by RT-PCR with gene specific primers derived from the less conserved 3'
non-coding regions of the genes. Consistent with their potential roles in muscle
development, strong expression of all five myomesin genes was detected in zebrafish
embryos during myogenesis. However, the five myomesin genes exhibited distinct
patterns of expression. Myomesin-2b was expressed the earliest and its expression
levels increased gradually during myogenesis. Myomesin-1b and myomesin-2a also
showed very high levels of expression after 24 hpf. myomesin-1a and myomesin-3
expression levels were not as strong as that of the other three myomesin genes (Fig.
11). These data indicate that the temporal expression pattern of myomesin genes in
zebrafish is highly regulated during development.
To determine the spatial patterns of expression of the various myomesin genes in
zebrafish embryos, we analyzed their mRNA expression in 48 hpf zebrafish embryos
by whole-mount in situ hybridization. Five gene-specific probes derived from the less
conserved 3'UTR non-coding regions were generated. The results showed that all five
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myomesin genes exhibited muscle-specific expression in zebrafish embryos (Fig. 12).
The levels of expression were consistent with the RT-PCR data. However, the five
myomesin genes exhibited different patterns of expression in cardiac and skeletal
muscles. The data showed that myomesin-1b and myomesin-2b were expressed in
both skeletal and cardiac muscles (Fig. 12F and L), whereas myomesin-1a, -2a, and -3
were only expressed in skeletal muscles in zebrafish embryos and not in cardiac
muscles (Fig. 12C, F, and O). Together, these data indicate that the five myomesin
genes exhibit distinct patterns of muscle-specific expression and that their expression
patterns are highly regulated.
3.4.3 Knockdown of myomesin-1b expression results in little or no effect on
skeletal muscle development
To determine the function of myomesin in muscle cell development and
sarcomere organization, we knocked down the expression of myomesin-1b, one of the
most abundantly expressed myomesin genes in zebrafish embryos, by using a splicing
MO (Fig. 13A). The effect on myomesin-1b splicing was determined by RT-PCR (Fig.
13B). The data showed that splicing of myomesin-1b transcripts was efficiently
blocked. Compared with native transcripts, the transcripts in the MO injected
embryos had a 16 bp deletion in exon 15. The deletion induces a frameshift in the
open reading frame resulting in the disruption of proper translation of myomesin-1b.
The splicing MO injected embryos were examined morphologically for 3 days after
injection. The knockdown embryos appeared morphologically normal. No or little
defects in muscle contraction or heart beat could be observed. To determine whether
the splicing MO may have any effects on myofibril organization, the sarcomeric
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organization of MO injected embryos was examined by immunostaining with anti-
myomesin, anti-α-actin, and anti-α-actinin specific antibodies. Little or no difference
in sarcomere organization could be detected in the MO injected embryos as compared
to the WT embryos (Fig. 13C–H). Together, these data indicate that myomesin-1b is
not required for myofibril organization during myofiber maturation.
3.4.4 Disruption of the myomesin-3 locus by red fluorescent protein (RFP)
trapping in zebrafish
Myomesin-3 is specifically expressed in the slow muscles of zebrafish embryos
(Schoenauer et al., 2007). A zebrafish myomesin-3 mutant was recently generated
using a RFP trap (Clark et al., 2011). The protein trap integration site in myom3
(mnGt0067) fish was recently mapped to an intron of the myomesin-3 gene (Clark et
al., 2011). It has been reported that the RFP protein trap integration results in over
99% reduction of myomesin-3 gene expression (Clark et al., 2011). To better
characterize the integration site and the effect of the RFP insertion on myomesin-3
gene expression, we analyzed the expression of myomesin-3-rfp chimeric mRNA
transcripts by RT-PCR (Fig. 14B). Sequence analysis revealed that the RFP
integration site was located within intron 24 of myomesin-3 (Fig. 14A). The RFP
integration resulted in the production of a myomesin-3-RFP fusion protein that
included the N-terminal 957 aa residues of myomesin-3 followed by 13 aa residues
coded by part of intron 24 plus an additional 11 aa residues coded by the sequence
upstream of the RFP coding sequence in the vector, and finally the RFP sequence (Fig.
14A). The myomesin-3-RFP fusion protein lacks the C-terminal sequence of 219 aa
residues.
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To determine the effect of RFP integration on myomesin-3 mRNA expression, we
carried out RT-PCR to amplify myomesin-3 transcripts and myomesin-3-rfp fusion
mRNA transcripts from total RNA from control and myomesin-3-RFP homozygous
embryos with specific primers (Fig. 14B). We observed strong expression of
myomesin-3-rfp fusion transcripts in myom3 (mnGt0067) homozygous zebrafish
embryos. However, no myomesin-3 transcripts could be detected in myom3
(mnGt0067) homozygous zebrafish embryos. This is consistent with the report that
the integration of the RFP trap significantly reduces the expression of the myomesin-3
mRNA transcripts to less than 1% of the normal levels (Clark et al., 2011).
3.4.5 Disruption of the myomesin-3 locus by RFP trapping has no effect on
sarcomere organization in slow muscles
To determine whether the disruption of myomesin-3 expression by the RFP
insertion could affect the M-line localization of myomesin-3, we analyzed myomesin-
3-RFP localization in myom3 (mnGt0067) homozygous fish embryos. Normal M-line
localization of myomesin-3-RFP was seen in slow muscles (Fig. 15C), suggesting
that the myomesin-3 N-terminal region contains the sequence required for the M-line
localization of myomesin-3. To determine whether the disruption of myomesin-3
expression by the RFP insertion could affect sarcomere organization in slow muscles,
we characterized the organization of thick and thin filaments and Z-lines in myom3
(mnGt0067) homozygous fish embryos. The results showed that blocking myomesin-3
expression by RFP insertion had little or no effect on sarcomere organization (Fig.
16). Both thick and thin filaments as well as Z-lines appeared normal in the slow
muscles of myom3 (mnGt0067) homozygous fish embryos (Fig. 16B, E, and H).
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Together, these data indicate that sarcomere organization is not affected by the RFP
insertion in the myomesin-3 gene locus. This is unexpected considering that the RFP
insertion in myomesin-3 resulted in the production of a truncated myomesin-3, and a
99% reduction in the expression of wild type myomesin-3 mRNA transcripts (Clark et
al., 2011).
3.4.6 Knockdown of myomesin-3 has no effect on sarcomere organization
and Smyd1b_tv1 M-line localization in slow muscles
The normal M-line organization of myomesin-3-RFP and the lack of sarcomeric
defects in myomesin-3-RFP homozygous fish was unexpected. To rule out the
possibility that myomesin-3-RFP may retain some myomesin-3 function involved in
M-line organization, a knockdown experiment was performed to directly inhibit
myomesin-3 expression using a myomesin-3 ATG-MO in zebrafish embryos. The
myomesin-3 ATG-MO was injected into myomesin-3-RFP embryos. Knockdown
efficiency was monitored by examining Myomesin-3-RFP expression in the injected
embryos at 48 hpf. The data showed that the myomesin-3 ATG-MO was highly
effective in knocking down the expression of myomesin3-RFP (Fig. 15D). To
determine the effect of myomesin-3 knockdown on sarcomere organization, we
analyzed sarcomere organization by immunostaining the embryos with specific
antibodies against myosin, α-actin, and α-actinin. The data showed that myomesin-3
knockdown embryos had normal thick and thin filament formation and Z-line
organization (Fig. 16C, F, and I). To test the effect of myomesin-3 knockdown on M-
line organization, we examined M-line organization using the EF-1α-Smyd1b_tv1-
EGFP transgenic line, as mentioned above, which expresses the Smyd1b_tv1-EGFP
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fusion protein on the M-line. The myomesin-3 ATG-MO was injected into
Smyd1b_tv1-EGFP zebrafish embryos. The M-line localization of Smyd1b_tv1-
EGFP was determined. The data showed that M-line localization of Smyd1b_tv1-
EGFP was normal in myomesin-3 knockdown embryos (Fig. 15H), suggesting that
the M-line structure was not disrupted by myomesin-3 knockdown. Collectively, these
data indicate that myomesin-3 is dispensable for sarcomere formation in the slow
muscles of zebrafish embryos.
3.4.7 Hsp90α1 and Unc45b are required for myomesin-3-RFP M-line
organization in slow muscles
It has been shown that Hsp90α1 and Unc45b are myosin chaperones that play
pivotal roles in myosin folding and sarcomere assembly (Du et al., 2008).
Knockdown or mutation of either hsp90α1 or unc45b leads to the complete disruption
of the sarcomeric organization of thick and thin filaments in both slow and fast
muscles (Du et al., 2008b; Bernick et al., 2010; Fig. 18A–C). The M-lines and Z-discs
have also been shown to be disrupted in fast muscles (Du et al., 2008b). However, the
effects of hsp90α1 or unc45b knockdown or mutation on M-line organization have
not been analyzed in the slow muscles of zebrafish embryos. To characterize the
function of Hsp90α1 and Unc45b in M-line organization, we knocked down hsp90α1
and unc45b expression in smyd1b_tv1-EGFP(+/-)*myomesin-3-RFP(+/+) fish
embryos, and analyzed the localization of Smyd1b_tv1-EGFP and myomesin-3-RFP.
The results showed that knockdown of hsp90α1 and unc45b resulted in little or no
sarcomeric localization of either Smyd1b_tv1-EGFP or myomesin-3-RFP in the slow
muscles of zebrafish embryos (Fig. 17). Together, these data indicate that Hsp90α1
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and Unc45b may play a direct role in M-line organization. Alternatively, because
Hsp90α1 and Unc45b are required for myosin thick filament assembly, the disruption
of thick filament formation by hsp90α1 and unc45b knockdown could lead to M-line
disorganization. Consistent with this idea, studies from our lab have shown that the
knockdown of myosin expression in slow muscles results in defective myomesin-3-
RFP localization (Xu et al., 2012).
It has been suggested that Unc45b and Hsp90α1 work as a complex and are
involved in regulating myosin stability (Srikakulam et al., 2008). The binding of
Unc45b to other proteins is dependent on the TPR domain, which is located at the N-
terminal end of Unc45b (Chadli et al., 2008). However, it has been reported that the
TPR domain of Unc45 is not essential for its chaperone function in C. elegans (Ni et
al, 2011). To determine whether the TPR domain of Unc45 is critical for its function
in zebrafish embryos, DNA constructs encoding Unc45bmyc or Unc45bΔTPRmyc were
coinjected with unc45b MO into the zebrafish embryos. Double immunostaining
analysis using the anti-MHC(F59) and anti-myc antibodies revealed that fibers
expressing Unc45bmycwere rescued. Clear thick filament organization was detected in
a mosaic pattern (Fig. 19D–F). However, those myofibers that expressed
Unc45bΔTPRmyc, which is a truncated form of Unc45b lacking the TRP domain,
showed severe defects without mosaic patterns (Fig. 18G–I). The loss-of-function of
the TRP truncated form of Unc45 confirms the previous hypothesis that the TPR
domain is required for Unc45b mediated protein-protein interaction, which plays
important roles in myofibrillogenesis. Together, these data indicate that Hsp90α1 and
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Unc45b are critical for sarcomeric organization of the M-line and that the TPR
domain of Unc45b is required for Unc45b function in zebrafish embryos.
3.4.8 Knockdown of smyd1b has no effect on the mRNA levels of myomesin
Our previous studies have shown that the knockdown of smyd1b severely
disrupts the sarcomeric localization of myomesin. Little or no myomesin can be
detected by immunostaining in smyd1b knockdown embryos. This indicates a critical
role for Smyd1 in the regulation of myomesin. However, whether the myomesin
expression level is affected at the transcriptional level or at the protein level in
smyd1b knockdown embryos is not clear. To determine the mechanism of regulation
of myomesin by Smyd1b, we performed RT-PCR analysis to compare the expression
levels of all five myomesin genes in smyd1b knockdown embryos. Our data showed
that there were no differences in the transcript levels of any of the five myomesin
genes in smyd1b knockdown embryos as compared to the WT control (Fig. 19).
These data indicate that Smyd1b is not involved in the transcriptional regulation of
myomesin. On the contrary, Smyd1b may be involved in the post-translational
modification of myomesin and/or myosin and may control myofibril assembly.
3.5 Discussion:
In this study, we characterized the temporal and spatial expression patterns of
five members of the myomesin gene family in zebrafish embryos. Functional analysis
of myomesin-1b and slow muscle specific myomesin-3 revealed that disruption of
their expression had little or no effect on sarcomere organization of skeletal muscles
in zebrafish embryos. On the contrary, knockdown of the molecular chaperones
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hsp90α1 and unc45b severely disrupted the M-line localization of myomesin-3 and
Smyd1b_tv1. Together, these data indicate that Hsp90α1 and Unc45b are required for
M-line organization; however, myomesin-1b and myomesin-3 are dispensable for M-
line formation in the sarcomere.
3.5.1 Characterization of myomesin genes in zebrafish
GeneBank and sequence analysis revealed that there are at least five myomesin
genes in the zebrafish. All five myomesin genes showed muscle specific patterns of
expression in zebrafish embryos. myomesin-1b and myomesin-2b exhibited both
skeletal and cardiac muscle expression. myomesin-1a, myomesin-2a, and myomesin-3
were only expressed in skeletal muscles. RT-PCR analysis revealed that myomesin-1b
and myomesin-2b exhibited higher expression levels than myomesin-2a and
myomesin-3. myomesin-1a only showed a mild expression level. These studies
indicate that the expression patterns of the various myomesin genes is highly
regulated in zebrafish embryos.
3.5.2 Loss of myomesin-3 and myomesin-1b has little effect on sarcomere
organization
It has been suggested that myomesins play a key role in myofibrillogenesis.
However, most of the suggested functions of myomesin are based on in vitro cellular
and biochemical studies. The lack of knockout or mutant models has impeded a clear
understanding of myomesin function in myofibrillogenesis. Moreover, no M-line-
related sarcomere diseases had been discovered before 2005 (Laing and Nowak,
2005). Although recent reports show that cardiac hypertrophy might be associated
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with a myomesin mutation in patients and that the knockdown of myomesin causes a
sarcomere defect in vitro (Siegert et al., 2011; Fukuzawa et al., 2008), whether
myomesin plays a critical role in sarcomere organization in vivo is still not well
understood.
Data from our studies demonstrate that the knockdown of myomesin-3 and
myomesin-1b expression has little or no effect on myofibril organization in the
skeletal muscles of zebrafish embryos. The lack of a muscle phenotype in the
knockdown embryos is surprising. It may suggest that these genes are not essential
for M-line organization. Alternatively, the highly conserved sequence of the five
myomesin genes in zebrafish and their redundant patterns of expression in skeletal
muscles suggest that there may be some functional redundancy between the different
myomesin genes.
It has been reported that myomesin-3 can dimerize in an antiparallel fashion via
the C-terminal end (Lange et al., 2005). This dimerization was suggested to have an
important role in M-line organization. Interestingly, our data showed that myomesin-
3-RFP lacking the C-terminal part of myomesin-3 is still localized to the M-line.
These results indicate that the C-terminal dependent dimerization of myomesin-3 may
not contribute to its M-line localization.
3.5.3 Hsp90α1 and Unc45b are required for M-line organization
Genetic and biochemical analyses have shown that chaperone-mediated myosin
folding and assembly is an integral part of myofibrillogenesis during muscle
development. It has been suggested that Hsp90α and Unc45b are required for
sarcomere organization. Recent biochemical studies support the hypothesis that
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Hsp90α and Unc45b, interact with Smyd1, forming a complex that is involved in
regulating myosin folding (Tan et al., 2006; Liu et al., 2008; Srikakulam et al, 2008;
Etard et al., 2008; Du et al., 2008). Consistent with their function in thick filament
assembly and sarcomere organization, data from this study demonstrate that the
knockdown of unc45b or hsp90α1 expression abolishes the M-line localization of
myomesin-3 and Smyd1b_tv1. The defective M-line organization in hsp90α and
unc45b knockdown embryos can be explained by their function on M-line proteins.
Our previous studies showed that the knockdown of slow muscle myosin heavy
chains disrupts sarcomere organization and the M-line localization of myomesin-3-
RFP. This is similar in effect to unc45b or hsp90α1 knockdown. This result suggests
the alternative explanation that the disruption of the M-line in unc45b and hsp90α1
knockdown embryos may indirectly result from the disruption of thick filament
organization.
Our TPR domain deletion study showed that Unc45bΔTPRmyc could not rescue
the myofibril defect caused by unc45b knockdown. This result is consistent with the
previous hypothesis that the TPR domain of Unc45 is critical for protein-to-protein
interaction with Hsp90, and is required for the formation of the regulatory complex
(Chadli et al., 2008).
3.5.4 Smyd1b and myomesin:
Our previous studies indicated that Smyd1b was involved in myomesin M-line
organization. Little or no myomesin could be detected in smyd1b knockdown
embryos. In this study, we demonstrate that the mRNA levels of all five myomesin
genes are unaffected by smyd1b knockdown. These data indicate that the loss of
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sarcomeric localization of myomesin is not due to lower levels of myomesin mRNA
expression in smyd1b knockdown embryos. Myomesin is thought to cross-link thick
filaments and play critical roles in sarcomere organization. Our previous data
demonstrated that Smyd1b_tv1 and myomesin-3 are co-localized on the M-line in
slow muscles. These data suggest the possibility that Smyd1 may be involved in the
modification or regulation of myomesin proteins. Alternatively, the loss of sarcomeric
localization of myomesin could be affected by the disruption of thick filaments in
smyd1b knockdown embryos. This theory is supported by our recent studies showing
that the knockdown of smyhc completely disrupts the M-line localization of
myomesin-3-RFP (Xu et al., 2012).
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Fig. 10. The phylogenetic tree analysis of zebrafish myomesin-1a, myomesin-
1b_tv1, myomesin-1b_tv2, myomesin-2a, myomesin-2b, and myomesin-3.
The phylogenetic tree analysis of the protein sequence of myomesin genes in
zebrafish, mice, and humans. (Zf: zebrafish, Homo: human, Mus: mouse)
62
B
Fig. 11. Developmental stage specific expression of the myomesin-1a, myomesin-1b
(tv1 and tv2 were detected using the same set of primers), myomesin-2a, myomesin-2b,
and myomesin-3 genes in zebrafish. Total RNA extracted from 0 hpf, 3 hpf, 6 hpf, 9 hpf,
12 hpf, 14 hpf, 19 hpf, 24 hpf, Day 2, Day 3, Day 4, Day 5, and Day 6 zebrafish embryos
was used for reverse transcriptase (RT)-PCR analysis. Different sets of primers were used
to detect myomesin-1a, myomesin-1b, myomesin-2a, myomesin-2b, and myomesin-3.
A. Time course RT-PCR analysis of the expression of myomesin-1a, myomesin-1b,
myomesin-2a, myomesin-2b, and myomesin-3. EF-1α was used as a positive control. N
stands for negative control without the cDNA template.
B. Densitometry roughly represents the expression levels of the different myomesin genes
from 0 hpf to Day 6.
A
63
Fig. 12. Whole-mount in situ hybridization showing the expression patterns
at 48 hours post fertilization of myomesin-1a, myomesin-1b, myomesin-2a,
myomesin-2b, and myomesin-3 using dig-labeled antisense probes. Lateral (A,
D, G, J, and M), dorsal (B, E, H, K, and N), and heart areas enlarged (C, F, I., L,
and O) views are shown. All five myomesin genes exhibited muscle specific
expression.Myomesin-1b and Myomesin-2b were expressed in both skeletal and
cardiac muscles. Myomesin-1a, myomesin-2a, and myomesin-3 were only




























WT WT Mo Mo
B
Fig. 13. Knockdown of myomesin-1b has little or no effect on skeletal muscle
development.
A. Location of the morpholino splicing blocker MyoM1b-MO1 (E15I15). MyoM1b-
MO1 was targeted to the exon15/intron15 junction and induced a 16 bp shift. This
indicates the ORF of myomesin-1b shifted in MO injected embryos.
B. RT-PCR result showed the defective splicing induced by the E15I15 Mo.
Compared with the native transcript, transcript from the E15I15 MO injected embryos
had a 16 bp shift, which was verified by sequencing.
C–H: myomesin, α-actin, and α-actinin antibody staining showed little or no effect on
sarcomere organization of knockdown embryos as compared to WT embryos at 48
hpf. (C) WT embryos, myomesin antibody staining. (D) WT embryos, α-actin
antibody staining. (E) WT embryos, α-actinin antibody staining. (F) myomesin-1b
knock-down embryos, myomesin antibody staining. (G) myomesin-1b knock-down
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Fig. 14. Diagram showing the gene trap integration in myomesin-3 gene
and the PCR strategy used for analyzing the expression of myomesin-3 and
myomesin-3-rfp mRNA transcripts.
A: the RFP gene trap is integrated in intron 24 of myomesin-3. A cDNA
fragment covering the junction site of myomesin-3 and rfp fusion was amplified
by RT-PCR. Additional sequence of 39 bp from intron 24 and 32 bp from the
vector sequence upstream of rfp was found in the myomesin-3-rfp fusion
transcript. myomesin-3 GenBank accession no. XM_001921030.
B: RT-PCR results showed the expression of myomesin-3 mRNA transcripts or


























Fig. 15. The effect of RFP gene trap insertion and myomesin-3 knockdown on M-
line organization in the slow muscles of zebrafish embryos.
A and B: morphological comparison of the myom3 (mnGt0067) homozygous control
(A) and myomesin-3 ATG-MO injected (B) embryos at 24 hpf.
C and D: the M-line localization of myomesin-3-RFP in myom3 (mnGt0067)
homozygous control (C) or myomesin-3 knockdown (D) embryos at 48 hpf.
E and F: wild-type embryos for GFP (E) and RFP (F) at 28 hpf and 48 hpf,
respectively.
G and H: sarcomeric localization of Smyd1b-EGFP at the M-lines in Smyd1b-EGFP

































Fig. 16. Sarcomere organization in the slow muscles of homozygous myomesin-3-
RFP and myomesin-3 knockdown zebrafish embryos.
A–C: anti-MyHC antibody (F59) staining shows thick filament organization in the
slow muscles of the control (A), homozygous myom3 (mnGt0067) (B), and myomesin-
3 knockdown (C) embryos at 28 hpf.
D–F: α-actin immunostaining shows the organization of thin filaments in the slow
muscles of the control (D), homozygous myom3 (mnGt0067) (E), and myomesin-3
knockdown (F) embryos at 28 hpf.
G–I: α-actinin immunostaining shows the organization of Z-lines in the slow muscles
of the control (G), homozygous myom3 (mnGt0067) (H), and myomesin-3 knockdown
(I) embryos at 28 hpf.
A B C
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Fig. 17. Effects of hsp90α1 and unc45b knockdown on the sarcomeric
localization of Smyd1b_tv1-EGFP and myomesin-3-RFP in zebrafish embryos.
Sarcomere localization of Smyd1b_tv1-EGFP (D: hsp90α1 knockdown (KD)
embryos, G: unc45b KD embryos) and myomesin-3-RFP (E: hsp90α1 KD
embryos, G: unc45b KD embryos) on smyd1b_tv1-EGFP(+/-)*myomesin-3-




















Fig. 18. Unc45bΔTPR protein cannot rescue the myofibril defect in unc45b
knockdown embryos. Unc45bmyc and Unc45bΔTPRmyc were visualized by
anti-myc antibody staining (red). Myosin thick filament organization was
determined by F59 antibody staining (green) in unc45b knockdown embryos.
A–C: antibody staining of unc45b knockdown control embryos at 27 hpf. (A)
F59 antibody, (B) anti-myc antibody, and (C) merge.
D–F: DNA construct encoding Unc45bmyc was co-injected with unc45bMO
into fish embryos and visualization was achieved by antibody staining at 27 hpf
(D) F59 antibody, (E) anti-myc antibody, and (F) merge.
G–I: DNA construct encoding Unc45bΔTPRmyc was co-injected with unc45b
MO into fish embryos and visualization was achieved by antibody staining at
27 hpf (G) F59 antibody, (H) anti-myc antibody, and (I) merge.
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1 2
P: EF1α MyoM1a MyoM1b MyoM2a MyoM2b MyoM3
3 4 5 6 7 8 9 10 11 12
cDNA: odd: WT. even: SmyD1bKD.
Fig. 19. Analysis of the expression pattern of the five myomesin genes in smyd1b
knockdown embryos by RT-PCR.
Total RNA was extracted form 48 hpf WT embryos (odd number) and smyd1b
knockdown embryos (even number). RT-PCR expression analysis of the different
myomesin genes by using different sets of primers. Primers: Lines 1–2: EF1α control.
Lines 3–4: myomesin-1a primers. Lines 5–6: myomesin-1b primers. Lines 7–8:
myomesin-2a primers. Line 9–10: myomesin-2b primers. Line: 11–12: myomesin-3
primers.
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Chapter 4: Effect of smyd1 knockdown on protein
methylation in zebrafish embryos
4.1 Abstract:
Myofibrillogenesis is a highly regulated process. Post-translational modification
plays critical roles in protein regulation. Various sarcomere proteins have been shown
to be methylated. However, the biological functions of such methylation and that of
the methyltransferases involved are not well understood. Smyd1 is a lysine
methyltransferase that is required for myofibril organization in zebrafish embryos.
We hypothesize that Smyd1 may control sarcomere assembly via protein methylation.
To better understand the mechanism of Smyd1 function in myofibrillogenesis, we
analyzed the protein methylation state in smyd1 knockdown embryos. The result
shows that the general protein methylation level decreases in smyd1 knockdown
embryos.
4.2 Introduction:
Smyd1 is a methyltransferase that is capable of methylating histone 3 lysine 4 in
vitro (Tan et al., 2006). We showed earlier that Smyd1b exhibits sarcomeric
localization in mature myofibers without any nuclear localization. This finding
indicates a potential role for Smyd1b in sarcomere organization by regulating non-
histone sarcomere proteins. Although it has been reported recently that
methyltransferase activity might not be required for the function of Smyd1 in
sarcomere assembly (Just et al., 2011), previous studies in our lab have shown that
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mutating the SET domain, which is required for the methyltransferase activity,
completely abolishes the biological function of Smyd1 (Tan et al., 2006).
Protein methylation has been suggested to play important roles in protein
stabilization/de-stabilization, activity, and protein-protein interaction (Yang et al.,
2009; Egorova et al., 2010; Zhang et al., 2012). To date, several sarcomere proteins,
such as myosin, actin, and creatine kinase, have been shown to be methylated at their
lysine residues (Tong and Elzinga, 1983; Iwabata et al., 2005). However, the
biological significance of such methylation and that of the methyltransferases
involved in sarcomere protein methylation are not well understood.
In this study, we characterized the overall protein methylation in wild-type and
smyd1 knockdown embryos. Our data show that the overall protein methylation levels
decrease in smyd1b knockdown embryos. Myosin protein levels also decrease upon
knocking down smyd1b. These data indicate that Smyd1 might be involved in the
regulation of sarcomere protein methylation and myosin protein quality control.
4.3 Materials and Methods:
4.3.1 Western blot analysis
Wild-type or smyd1b MO-injected zebrafish embryos at 72 hpf (50 embryos
each) were dechorionated manually and crushed gently to remove the yolk by
triturating with a glass pipet. The embryos were lysed in 100 µ L lysis buffer
containing DTT, PMSF, and protease inhibitor (P8340, Sigma) for 30 minutes and
mixed with 100 µL 2X SDS loading buffer (0.125 M Tris-Cl, pH 6.8; 4% SDS; 20%
glycerol; 0.2 M DTT; 0.02% bromophenol blue). Samples were boiled for 5 minutes,
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and the proteins were separated on a 7.5% SDS-polyacrylamide gel. Following SDS-
polyacrylamide gel electrophoresis, the proteins were transferred to a polyvinylidene
fluoride (PVDF) microporous membrane (Immobilon-FL, Millipore, MA, USA)
using a standard electrophoresis transfer system (Hoefer, MA, USA). Membranes
were treated for 10 minutes with Antigen Pretreatment Solution (SuperSignal
Western Blot Enhancer Kit, Thermo Scientific, IL, USA) and were blocked with 5%
nonfat milk in PBST (1X PBS, 0.1% Tween-20) for 1 hour at room temperature.
After blocking, membranes were incubated with primary antibody for 1 hour in
Primary Antibody Diluent (Super Signal Western Blot Enhancer Kit, Thermo
Scientific) followed by three washes with PBST for 10 minutes each. Membranes
were incubated with secondary antibody for 1 hour at room temperature in 5% nonfat
milk in PBST followed by five washes with PBST for 10 minutes each. Blots were
developed using the Pierce ECL Western Blotting Substrate (Thermo Scientific)
according to the manufacturer's instructions.
4.3.2 MG132 proteasomal inhibitor treatment
24 hpf WT and smyd1b knockdown embryos were transferred in groups of 50
into 8-well plates containing 10 mL fish water. smyd1b knockdown embryos were
treated with 2uM proteasomal inhibitor MG132 in DMSO for 48 hpf at 28°C. Control
WT and smyd1b embryos were treated with DMSO. The final concentration of
DMSO was 1% for both the treated and control wells (Winder et al., 2011).
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4.4 Results:
4.4.1 Knockdown of smyd1b affects protein methylation in zebrafish
embryos
To better understand the role of Smyd1b in protein methylation, we carried out
Western blot analysis in smyd1b knockdown embryos using an anti-methyl lysine
specific antibody. Compared with WT control embryos, the methylation levels of
several proteins were significantly reduced in the smyd1b knockdown embryos
although Coomassie blue staining showed that the general protein levels were
unchanged (Fig. 20A and B). Among the proteins with reduced methylation, a protein
with molecular weight 220 kD may represent myosin heavy chain.
The reduced levels of protein methylation could be due to decreased protein
accumulation. To test this idea, we analyzed myosin expression in smyd1 knockdown
embryos. Consistent with previous results, we showed that the myosin protein levels
were also significantly lower by Western blot using a myosin heavy chain specific
antibody (Fig. 20C). It has been suggested that myosin can be ubiquitinated at lysine
residues and that this increases its degradation rate in C. elegans (Landsverk et al.,
2007). This finding indicates that myosin degradation could be regulated by the
ubiquitin-proteasome pathway. Previous studies in our lab have demonstrated that
knockdown of smyd1 significantly reduces myosin protein accumulation in zebrafish
embryos (Li et al., unpublished). It has been shown that treating worms with the
proteasomal inhibitor MG132 efficiently blocks ATP-dependent myosin degradation
(Landsverk et al., 2007). A new report in a zebrafish model demonstrated that the
phenotype of muscular dystrophy could be significantly reduced in dystrophic
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zebrafish larvae by treating with the proteasomal inhibitor MG132 (Winder et al.,
2011). Thus, to determine whether inhibiting proteasome activity could slow down
myosin protein degradation in smyd1b knockdown embryos, we treated the smyd1b
knockdown embryos with MG132 for 48 hours. The results showed that myosin
protein levels were not increased in MG132 treated smyd1b knockdown embryos
when compared with untreated knockdown embryos (Fig. 21A). In addition, the
general protein methylation levels showed no difference between smyd1b knockdown
embryos and smyd1b knockdown embryos treated with MG132 (Fig. 21C).
4.4.2 Knockdown of smyd1b results in increased Hsp90α expression
It has been suggested that Hsp90α and Smyd1 may form a complex that is
involved in regulating myofibrillogenesis (Tan et al., 2006). Consistent with a recent
report showing that hsp90α1 mRNA levels were higher in smyd1 deficient (fla mutant)
embryos (Just et al., 2011), our data revealed that Hsp90α protein levels were
increased in smyd1b knockdown embryos (Fig. 21B). The increased Hsp90α levels
may indicate a potential Smyd1b-mediated regulatory mechanism of Hsp90α
expression or protein stability in zebrafish embryos. Together, these data indicate that
the knockdown of smyd1b might affect protein methylation and alter Hsp90α
expression levels in zebrafish embryos.
4.5 Discussion:
4.5.1 Smyd1b and protein methylation:
Smyd1 is a lysine methyltransferase required for sarcomere organization. It can
methylate histone 3 lysine 4 in vitro (Tan et al., 2006). Some reports show that Smyd
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may be also involved in non-histone protein methylation (Yang et al., 2009; Donlin et
al., 2012). However, whether Smyd1 is involved in protein methylation in vivo is still
not clear, as is the methylation target(s) of Smyd1. In this study, we analyzed overall
protein methylation in zebrafish embryos, and showed that protein methylation levels
were decreased in smyd1b knockdown embryos as compared to WT controls. In
addition, we showed a significant reduction of myosin methylation in smyd1
knockdown embryos. We speculate that methylation of myosin by Smyd1 is required
for its folding and stability. Hence, the knockdown of smyd1 expression may result in
poor methylation of myosin proteins, thus leading to increased degradation.
It has been reported that proteasomal inhibitors efficiently block myosin
degradation in C. elegans (Landsverk et al., 2007). However, our results show that the
myosin protein levels were not different in smyd1b knockdown embryos with or
without treatment with MG132. These data indicate either that myosin degradation in
zebrafish does not occur through the ubiquitin-proteasome pathway or that the
proteasomal inhibitor MG132 is not as effective in zebrafish as it is in worms.
4.5.2 Smyd1b and Hsp90α:
Hsp90α function relies on cofactors that provide additional binding specificities
or enzymatic activities. Co-immunoprecipitation analysis revealed that Smyd is
associated with Hsp90α and Unc45b, which are indicated to be molecular chaperones
associated with myosin folding (Li et al, unpublished data). It has been shown that the
knockdown of smyd1 significantly upregulates hsp gene expression. In this study, we
showed that the protein levels of Hsp90α were increased in smyd1b knockdown
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embryos as compared to WT controls. These data indicate that Smyd1 is involved in
the regulation of Hsp90α in zebrafish.
Non-histone methylation has been shown to play important roles in regulating
protein stability (Yang et al., 2009). Recent studies have shown that Smyd2 is capable
of methylating Hsp90α on lysine209 and lysine615 and that the methylation of
Hsp90α is critical for its function in regulating sarcomere organization (Abu-Farha et
al., 2011; Donlin et al. 2012). Lysine615 of Hsp90α can also be ubiquitinated
(Kundrat and Regan, 2010), indicating that methylation and ubiquitination might
compete to regulate this lysine residue and hence regulate Hsp90α protein stability.
Sequence analysis showed that Smyd1 and Smyd2 are highly conserved, potentially
indicating conserved function of Smyd1 and Smyd2. Thus, the regulation of Hsp90α
by Smyd1b might be similar to its regulation by Smyd2, in that it is mediated by
directly affecting the methylation status of Hsp90α. Alternatively, Smyd1 may affect










Fig. 20. Analysis of protein methylation in smyd1b knockdown 3 dpf embryos by
Western blot.
A. Coomassie blue staining showing protein expression in WT control and smyd1b
knockdown embryos.
B. Protein methylation in WT control and smyd1b knockdown embryos by Western blot
using anti-methyl lysine antibody
C. Myosin heavy chain protein levels in WT control and smyd1b knockdown embryos

















Fig. 21. Analysis of Hsp90 and Myhc protein levels in smyd1b knockdown
embryos after treatment with the proteasomal inhibitor MG132.
A. Myhc protein levels significantly reduced in smyd1b knockdown embryos
and were not rescued by MG132.
B. Hsp90α protein levels increased in smyd1b knockdown embryos with and
without the treatment with MG132.
C. The general protein methylation levels in smyd1b knockdown embryos
were not affected by MG132 treatment.
D. Coomassie blue staining showing protein expression in WT control,
smyd1b knockdown embryos, and smyd1b knockdown embryos treated with
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